Morpholino

MO4-pycard

ID

ZDB-MRPHLNO-170915-8

Name

MO4-pycard

Previous Names

None

Target

pycard (1)

Sequence

5' - GCTGCTCCTTGAAAGATTCCGCCAT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO4-pycard

Expressed Gene	Anatomy	Figures
gata1a	whole organism	Fig. 4 from Tyrkalska et al., 2019
spi1b	whole organism	Fig. 4 from Tyrkalska et al., 2019

Phenotype

Phenotype resulting from MO4-pycard

Phenotype	Fish	Figures
cysteine-type endopeptidase activity decreased occurrence, abnormal	i114Tg + MO4-pycard	Fig. 1, Fig. 4 from Tyrkalska et al., 2019
neutrophil decreased amount, abnormal	i114Tg + MO4-pycard	Fig. 1, Fig. 4 from Tyrkalska et al., 2019
nucleate erythrocyte increased amount, abnormal	cz3325Tg + MO4-pycard	Fig. 1 from Tyrkalska et al., 2019

Phenotype of all Fish created by or utilizing MO4-pycard

Phenotype	Fish	Conditions	Figures
whole organism decreased life span, abnormal	WT + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2017
innate immune response decreased process quality, abnormal	WT + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2017
cysteine-type endopeptidase activity decreased process quality, abnormal	WT + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2017
nucleate erythrocyte increased amount, abnormal	cz3325Tg + MO4-pycard	control	Fig. 1 from Tyrkalska et al., 2019
neutrophil decreased amount, abnormal	i114Tg + MO4-pycard	control	Fig. 1, Fig. 4 from Tyrkalska et al., 2019
cysteine-type endopeptidase activity decreased occurrence, abnormal	i114Tg + MO4-pycard	control	Fig. 1, Fig. 4 from Tyrkalska et al., 2019
cysteine-type endopeptidase activity decreased process quality, abnormal	WT + MO1-caiap + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2017
innate immune response decreased process quality, abnormal	WT + MO1-caiap + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2017
whole organism decreased life span, abnormal	WT + MO1-caiap + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 7 from Tyrkalska et al., 2017
cysteine-type endopeptidase activity decreased occurrence, abnormal	c264Tg; utn6Tg + MO4-pycard	control	Fig. 2 from Tyrkalska et al., 2019
whole organism gata1a expression increased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO4-pycard	control	Fig. 4 from Tyrkalska et al., 2019
whole organism decreased life span, exacerbated	mitfa^w2/w2; mpv17^a9/a9 + MO4-pycard	bacterial treatment by injection: Salmonella enterica subsp. enterica serovar Typhimurium	Fig. 4 from Tyrkalska et al., 2019
whole organism Ab2-gata1a labeling increased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO4-pycard	control	Fig. 4 from Tyrkalska et al., 2019
whole organism spi1b expression increased amount, abnormal	mitfa^w2/w2; mpv17^a9/a9 + MO4-pycard	control	Fig. 4 from Tyrkalska et al., 2019

Citations